Seeing Is Believing
STRO is currently covered by 5 analysts with an average price target of $14.18. This is a potential upside of $10.35 (270.23%) from yesterday's end of day stock price of $3.83.
Sutro Biopharma's activity chart (see below) currently has 26 price targets and 38 ratings on display. The stock rating distribution of STRO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 31.51% with an average time for these price targets to be met of 225.29 days.
Highest price target for STRO is $17, Lowest price target is $8, average price target is $14.18.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 26-Mar-2024. First documented stock forecast 22-Oct-2018.
Currently out of the existing stock ratings of STRO, 22 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$4.17 (108.88%)
12
1 months 9 days ago
2/8 (25%)
$3.82 (91.39%)
708
Buy
17
$13.17 (343.86%)
17
1 months 9 days ago
1/9 (11.11%)
$12.82 (306.70%)
24
Buy
12
$8.17 (213.32%)
16
1 months 9 days ago
0/6 (0%)
$7.82 (187.08%)
Buy
12
$8.17 (213.32%)
18
5 months 20 days ago
4/9 (44.44%)
$9.54 (387.80%)
402
Buy
25
$21.17 (552.74%)
21
1 years 3 months 22 days ago
2/5 (40%)
$17.13 (217.66%)
172
What is STRO (Sutro Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?
Which analyst has the current lower performing score on STRO (Sutro Biopharma) with a proven track record?
Which analyst has the most public recommendations on STRO (Sutro Biopharma)?
Which analyst is the currently most bullish on STRO (Sutro Biopharma)?
Which analyst is the currently most reserved on STRO (Sutro Biopharma)?